Guides
Storage and cold chain best practices
Cold chain — the unbroken sequence of temperature-controlled storage from manufacture to use — determines whether a peptide arrives with the potency printed on the label. This guide covers what practical cold chain looks like for research-supply peptides.
6 minute read · Last reviewed 2026-07-13
Why cold chain is a chain
The phrase 'cold chain' captures something important about pharmaceutical logistics: temperature control has to be maintained across every link between manufacturing and end use, and the chain is only as strong as its weakest link. A vial that was stored perfectly at −20 °C at the manufacturer, refrigerated appropriately at the distributor, and returned to refrigeration by the end user, but that spent 48 hours sitting on a doorstep in summer heat during shipping, is a vial whose potency at the point of injection is uncertain. The cold chain concept applies to every peptide product regardless of whether it is a commercial FDA-approved biological or a research-supply lyophilized vial. For lyophilized products the cold chain requirement is somewhat forgiving (dry powder tolerates temperature excursions much better than solution), but it is not absent. For liquid products the requirement is strict.
Temperature ranges and what they preserve
The commonly-referenced temperature ranges are freezer (−20 °C or lower), refrigerator (2–8 °C, often referred to as 'refrigerated' or 'cold-chain'), and room temperature (approximately 15–25 °C). Each range trades stability for accessibility. Freezer storage gives the longest shelf life for lyophilized peptides but is inconvenient for daily access. Refrigerator storage is the working default for both lyophilized (unopened) and reconstituted vials — accessible for daily use and preserves stability for weeks to months for most peptides. Room temperature storage is acceptable for lyophilized peptides for short periods (days to weeks depending on the compound), but is not acceptable for reconstituted aqueous solutions for anything but very brief periods. Prolonged room-temperature exposure of a reconstituted vial should be treated as a stability event: the vial may still be usable but its beyond-use date should be shortened.
Shipping considerations for research supply
Research-supply peptides are typically shipped with ice packs or dry ice in insulated packaging designed to maintain refrigerated or frozen temperature during transit. The insulated packaging is rated for a specific transit time (commonly 24–48 hours for ice-pack shipments, longer for dry ice). Shipments that arrive on time with intact packaging and coolant remaining are generally considered to have maintained cold chain. Shipments that arrive with all coolant melted, or that were delayed enough that the insulation would have failed during transit, are cold-chain-compromised. The peptide may still be usable — lyophilized peptides tolerate room-temperature exposure for extended periods — but the manufacturer's stability guarantee is voided by the excursion. Documenting shipping temperature (with an included data logger for critical shipments) is standard practice for clinical-trial supply and increasingly for research supply. For end users, unpacking and refrigerating within a few hours of receipt is the appropriate practice.
Home refrigeration realities
A home refrigerator typically operates around 2–5 °C, which is within the standard refrigerator range. But home refrigerators have practical considerations that a laboratory refrigerator does not. Door shelves experience temperature fluctuations every time the door opens — a peptide vial stored on the door shelf may repeatedly cycle above 8 °C. The back of the middle shelf is usually the most temperature-stable location. Storing peptide vials near the freezer compartment (which some refrigerators have at the top) can produce localised sub-zero exposure that inadvertently freezes reconstituted vials — an unintended freeze-thaw cycle. The vegetable crisper may be warmer than other locations. The practical translation: store peptide vials on a stable middle-shelf location, not on the door, not next to the freezer, and check periodically with a thermometer that the actual temperature at that location is within range. Most home refrigerators are within range at most locations, but assumption is not verification.
Cold-chain quick check
Inspect shipping packaging on arrival — coolant remaining, insulation intact, no obvious damage.
Refrigerate within a few hours of receipt (freezer if the label specifies freezer storage).
Store vials in a stable middle-shelf location, not on the door, not near the freezer compartment.
Verify refrigerator temperature with a dedicated thermometer at the storage location.
Document any temperature excursion during shipping or storage — the manufacturer's stability window applies only within the specified range.
Aliquot reconstituted solutions if long-term storage is required, to minimise freeze-thaw cycling.
Related on Healthy Mango
Continue exploring
Editorial paths through the library. Pick one and follow the trail.
Guides
Understanding evidence levels
How to read the evidence meter on every compound page.
→
Guides
Understanding GLP-1 research
A tour of the GLP-1 research landscape, from receptor to phase-3 trial.
→
Guides
Understanding GIP biology
GIP receptor biology, why it was dismissed, and how tirzepatide vindicated it.
→
Guides
Understanding glucagon biology
Native glucagon physiology, why triple agonism uses it, and the counter-intuitive weight-loss story.
→
Guides
Growth hormone secretagogues explained
GHRH analogues, ghrelin mimetics, and why the two systems combine synergistically.
→
Guides
Melanocortin biology
α-MSH, MC1R–MC5R receptor selectivity, and how one accidental observation launched two approved drugs.
→
Guides
Tissue repair peptides
BPC-157, TB-500, GHK-Cu and KPV — how their mechanisms complement one another.
→
Guides
Mitochondrial peptides
MOTS-c retrograde signalling, SS-31 cardiolipin targeting, and where the evidence honestly stops.
→
Guides
Anti-inflammatory peptides
KPV, BPC-157, thymosin alpha-1, and why anti-inflammatory activity is a peptide-therapy foundation.
→
Guides
Copper peptides
GHK-Cu as the paradigm copper peptide — mechanism, dermatology evidence, and honest limits.
→
Guides
Understanding peptide half-life
What t½ actually measures, why engineering it changes clinical use, and pulsatile vs continuous.
→
Guides
Bioavailability explained
Why peptides are injected — first-pass metabolism, gut enzymes, and the emerging oral exceptions.
→
Guides
Animal research vs human research
Why the mouse works, why the human sometimes doesn't, and how to read that gap.
→
Guides
How to read a clinical trial
Sample size, primary endpoint, blinding, effect size — the anatomy of a trial reference.
→
Guides
Why some peptides become medicines
Patents, sponsors, endpoints, market size — the structural filters that pick which peptides become drugs.
→
Guides
Laboratory reconstitution principles
Vial mass vs concentration, diluent choice, aseptic technique — the concepts every reconstitution page assumes.
→
Guides
Lyophilized vs liquid preparations
Why the format is chosen at manufacturing, and what it means for handling and shelf life.
→
Guides
Sterility and laboratory handling
The mechanics of aseptic technique and why sterility is not just a checklist item.
→
Guides
Understanding peptide stability
Hydrolysis, oxidation, aggregation, interface denaturation — the four failure modes.
→
Guides
Buffer selection and practical considerations
When plain water is not enough — pH, tonicity, and the compounds that need buffering.
→
